Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Global equities rose to new highs this week on hopes for a U.S.-Iran peace deal, but Barclays strategist Emmanuel Cau cautions that a durable, broader market rally requires both reopening of the Strait of Hormuz and participation beyond the stretched semiconductors trade. Barclays points to liquidity support, strong first-quarter earnings driven by…
Federal Reserve Governor Stephen Miran said he hopes that Jerome Powell’s continued service on the Fed’s board after his chairmanship concludes will be limited to a clear transition period. Miran, speaking on Fox Business Network’s 'Mornings with Maria', emphasized the need to avoid divided loyalties and uncertainty about who is in charge. Powell h…
Qualcomm Inc. stock jumped about 6% Friday morning following an upgrade from Daiwa Securities analyst Louis Miscioscia, who moved the chipmaker from Neutral to Outperform and set a $225 price target. The firm highlighted longer-term revenue growth opportunities tied to data center CPUs, physical computing and edge AI even as Qualcomm’s fiscal third…
Barclays analysts said they expect Home Depot and Lowe's to report first-quarter results a bit above consensus, citing stabilizing demand, easier year-over-year comparisons and attractive valuations. The firm warned that progress on interest rates and housing activity has been slower than anticipated, but its company and supplier trackers show Q1 t…
Zeta Global ($17.31) combines strong top-line growth and growing free cash flow with modest leverage and a valuation that looks like adtech, not SaaS. We favor a long trade into strength with a $24.90 target and a $14.00 stop, horizon 180 trading days.
Plains All American Pipeline, L.P. reported solid first-quarter 2026 financial results, with net income attributable to PAA of $152 million and net cash provided by operating activities of $418 million. The company increased its full-year 2026 Adjusted EBITDA guidance midpoint by $130 million to $2.88 billion, citing a strong oil macro environment …
Traws Pharma, a clinical-stage biopharmaceutical company listed on NASDAQ, announced plans to advance clinical candidates targeting hantavirus infections, which currently have no approved treatments and carry a high fatality rate. Building on its expertise in antiviral drugs for negative-strand RNA viruses, Traws aims to rapidly identify and develo…
Plus Therapeutics announced that key clinical and translational data from their Phase 1 ReSPECT-LM trial of REYOBIQ were presented at the 2026 American Association of Neurological Surgeons meeting. The data demonstrated encouraging survival outcomes, favorable safety profiles, and potential immune-modulatory effects in treating leptomeningeal metas…
The European Commission has told Alphabet unit Google that a previous proposal aimed at addressing regulatory concerns was inadequate and has allowed the company more time to engage and present a stronger remedy. Commission spokesperson Thomas Regnier said Google is defending itself while working to produce a solution that fully tackles issues rais…
Exodus Movement, Inc. has launched XO Cash, the first stablecoin specifically designed for AI agents, enabling secure and self-custodial spending by AI agents without requiring them to manage private keys. The product integrates with Exodus Pay on the Solana blockchain and offers developer tools to create agent wallets with customizable spending ru…
JPMorgan upgraded ams-Osram to Neutral from Underweight and raised its price target to CHF 11.80, citing an expanded Micro LED opportunity for AI data centers. The move follows first-quarter results that suggested the addressable market could arrive sooner and at a larger scale, prompting the bank to raise revenue and adjusted EBITDA forecasts for …
UBS downgraded HelloFresh from Buy to Neutral and cut its price target to €4.70 from €6.10 after the meal-kit group's first-quarter results and cautious second-quarter guidance. While Q1 revenue and adjusted EBITDA beat consensus modestly and showed some sequential easing in declines, management's outlook for Q2 and explanations for the lack of imp…
Capricor Therapeutics said it filed a lawsuit against Nippon Shinyaku Co., Ltd. and its U.S. unit NS Pharma Inc., accusing the pair of failing to ready distribution for Deramiocel, an investigational cell therapy for Duchenne muscular dystrophy. The legal action coincided with a sharp drop in Capricor stock and a decline in Nippon Shinyaku shares. …
iBio, a NASDAQ-listed biotechnology company, has appointed Elizabeth Stoner, M.D., M.S., a seasoned biotech executive, to its Board of Directors. The move comes as iBio prepares to initiate its first human clinical trials for treatments targeting obesity and pulmonary hypertension associated with heart failure. Stoner's extensive experience in biot…
Expedia's stock fell sharply in pre-market trading after the company said that the ongoing conflict in the Middle East and a U.S. travel advisory for Mexico cut about 200 basis points from its quarter-over-quarter bookings and room-night growth. The disruptions, which include airspace closures and elevated cancellations beyond the immediate region,…
Apple shares climbed 0.80% after Wedbush raised its price target on the stock from $350 to $400, pointing to the company’s expanding role in consumer AI and a strategy that could bring new services revenue. The firm sees broad adoption of Apple-delivered AI, partnership activity in China with Alibaba, and possible hardware redesigns around the iPho…
UBS downgraded Swiss Life Holding AG to a sell rating from neutral while keeping a CHF 850 price target, following a detailed sum-of-the-parts valuation that produced a CHF 670-960 per-share range. The bank flagged higher European interest rates and stretched capital returns as key downside risks, and left earnings forecasts broadly unchanged.
Treace Medical Concepts reported first quarter 2026 revenue of $47.2 million, a 10% decrease compared to Q1 2025, with a net loss of $18.0 million. The company launched its SuperBite™ Compression Screw System and expanded its patent portfolio. Despite the revenue decline, it reaffirmed its full-year 2026 revenue guidance of $202 million to $212 mil…
Sagtec Global Limited announces its partner Stateight Sdn Bhd has won the Asia Pacific Property Award 2026-2027 for a residential development project in Malaysia. This award reinforces Sagtec's ongoing collaboration in funding and providing AI Smart Home solutions for an 84-unit townhouse project, integrating advanced smart home technologies and ex…
GigaCloud Technology Inc announced that its CEO, Larry Wu, will present at the 21st Annual Needham Technology, Media, & Consumer Conference. The company, specializing in end-to-end B2B ecommerce technology solutions for large parcel merchandise, will also host virtual investor meetings during the event.
Tvardi Therapeutics announced its first quarter 2026 financial results and provided updates on its clinical programs targeting STAT3-driven diseases. The company expects topline data for its next-generation STAT3 inhibitor TTI-109 from a healthy volunteer study in June 2026 and Phase 1b/2 trial results for TTI-101 in hepatocellular carcinoma in the…
MapLight Therapeutics, a clinical-stage biopharmaceutical company specializing in central nervous system disorders, announced its management team's participation in the 2026 RBCCM Global Healthcare Conference and the 2026 Jefferies Global Healthcare Conference. The company focuses on developing circuit-specific pharmacotherapies using a novel disco…
TeraWulf Inc. reported its Q1 2026 financial results showing $34.0 million total revenue including $21.0 million from high-performance computing (HPC) lease revenue, highlighting its transition towards stable, contracted revenue. The company energized 60 MW of HPC capacity at its Lake Mariner facility, progressing on key construction projects, and …
Boundless Bio reported first quarter 2026 financial results highlighting continued enrollment in its KOMODO-1 first-in-human clinical trial of BBI-940, an oral selective kinesin degrader targeting oncogene amplified cancers. The company presented promising preclinical data at AACR 2026 demonstrating robust anti-tumor activity and tumor regressions …
Hyperion DeFi, the first U.S. publicly listed DeFi company building on the Hyperliquid blockchain, has completed a public offering of 2,777,778 shares of common stock at $3.60 per share, raising approximately $10 million before expenses. The proceeds will be used to fund the company’s HYPE token treasury strategy and for general corporate purposes.…
